J&J Wins Jury Verdict Vs. Boston Scientific In Patent Suit Over Drug-Coated Stent

Law360, New York (March 26, 2005, 12:00 AM EST) -- Johnson & Johnson is emerging triumphantly from its patent litigation against its rivals in the highly lucrative market for drug-eluting stents, winning a second major victory this month in a jury verdict that could lead to hundreds of millions of dollars in damages.

On Thursday, a federal jury in Delaware ruled for J&J in the retrial of a four-year-old lawsuit against Boston Scientific over a patent for a drug-eluting coronary-artery stent.

The jury, in the U.S. District Court for the District of Delaware, found that a...
To view the full article, register now.